EurekAlert!

SOPHiA GENETICS announces poster presentations at ESMO 2024

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and ...
Nasdaq

Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ...

WATERTOWN, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of ...
Seeking Alpha

MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference

LONDON and NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings (MGTX) plc , a vertically integrated, clinical stage genetic medicine company, today announced a poster presentation at the ...
Labroots

Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2026

Labroots is excited to announce our 14th Annual Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2026 held on May 13th, 2026! The Precision Medicine: Genomics, ...
Business Wire

NewLink Genetics Describes the Differentiated Mechanism of Action of Indoximod in AACR Poster Presentation

AMES, Iowa-- (BUSINESS WIRE)-- NewLink Genetics Corporation (NASDAQ:NLNK) today presented a poster entitled “Indoximod modulates AhR-driven transcription of genes that control immune function ” in the ...